Oncomine Myeloid MRD (RUO) Assays

More comprehensive, more informative, more streamlined myeloid MRD detection

The Ion Torrent Oncomine Myeloid MRD Assays (RUO) on the Ion GeneStudio S5 System is a complete NGS testing solution for myeloid measurable residual disease (MRD) research. Highly sensitive AmpliSeq HD technology enables a limit of detection as low as 0.05% allele frequency.

Unlike traditional methods, NGS allows you to obtain informative data across a broad range of biomarkers simultaneously. A DNA and an RNA assay enable comprehensive assessment of genetic alterations, including SNVs, indels, and gene fusions. This streamlined approach to MRD analysis also features a complete informatics and reporting solution that simplifies data analysis and interpretation

Video Player is loading.
Current Time 0:00
Duration 2:45
Loaded: 0%
Stream Type LIVE
Remaining Time 2:45
 
1x
    • Chapters
    • descriptions off, selected
    • subtitles off, selected
    • en (Main), selected

    On Demand Webinar: Genomic profiling from initial assessment to detection of measurable residual disease (MRD): how NGS can rapidly deliver key insights for myeloid neoplasms.

    Dr. Bevan Tandon will review ongoing research in his laboratory using the Oncomine Myeloid Assay GX, an NGS-based test capable of delivering results in just 1-2 days. He will also share his experience with the upcoming Oncomine Myeloid MRD Assay (RUO), a highly sensitive NGS test for measurable residual disease (MRD) assessment that can identify mutations occurring at very low frequencies. Dr. Tandon will share recent analytical data from his team and offer his perspective on the value of NGS in hematopathology studies.

    Bevan Tandon, MD

    Director, Hematopathology and Molecular Pathology


    MRD Assay content summary

    The assays feature DNA and RNA targets for myeloid MRD analysis, allowing simultaneous profiling of single nucleotide variants (SNVs), insertions and deletions (indels), tandem duplications, and key gene fusions.

     

    These carefully curated targets are relevant for all categories of myeloid neoplasms, including Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), and Myeloproliferative Neoplasms (MPN) samples.

     

    DNA panel

    • 33 genes, including 2 full genes and FLT3-ITDs
    • Optional 22-amplicon micro-haplotype panel for
      chimerism analysis
    DNA Assay - Gene Targets
    ABL1 FLT3** NRAS TP53*
    ASXL1 GATA2 PHF6 U2AF1
    BCOR IDH1 PTPN11 WT1
    BRAF IDH2 RUNX1  
    CALR JAK2 SETBP1  
    CBL KIT SF3B1  
    CEBPA* KRAS SH2B3  
    CSF3R MPL SRSF2  
    DNMT3A MYD88 STAG2  
    EZH2 NPM1 TET2  

    RNA panel

    • 42 fusion driver genes
    • 990 unique fusions
    • 6 genes with exon splicing variants
    • 5 expression control genes
    RNA Assay - Fusion Driver Genes Expression Controls Exon Splicing Variants
    ABL1 FUS MYBL1 RARA ABL1 KMT2A
    ABL2 GLIS2 MYH11 RARB GUSB RUNX1
    ALK HMGA2 NOTCH1 RARG PSMB2 NOTCH1
    BCL2 JAK2 NTRK1 RET PUM1 ETV6
    BRAF KAT6A (MOZ) NTRK2 RUNX1 TRIM27 IKZF1
    CCND1 KAT6B NTRK3 TAL1   NTRK1
    CREBBP KMT2A (includes PTD)* NUP214 TCF3    
    CSF1R MECOM NUP98 TCF4    
    EGFR MLLT10 PAX5 TFE3    
    ETV6 MRTFA (MLK1) PDGFRA ZNF384    
    FGFR1   PDGFRB      

    Chimerism analysis

    An optional 22-amplicon DNA panel is included for chimerism analysis in post–allogeneic stem cell transplantation (allo-HSCT) research samples.

     

    This innovative NGS technique measures the ratio of donor/recipient DNA down to 0.2% allele frequency. Unlike traditional methods that rely on qualitative analysis, NGS provides digital quantification of allele mixtures to identify low-frequency, disease-associated markers with high sensitivity.

    Chimerism Analysis

    Streamlined workflow

    GeneStudio S5 NGS System

    The Oncomine Myeloid MRD Assays (RUO) include a fully integrated workflow based on the Ion GeneStudio S5 System. The entire process can be completed in 2–3 days with roughly 2 hours of hands-on time.


    Integrated informatics and reporting

    The solution includes an integrated analysis pipeline that allows labs to easily analyze samples without needing deep informatics expertise typically required for other assays.

     

    Easily visualize allele frequencies for target genes over a time series using Ion Reporter analysis tools.

    Ion Reporter

    Ordering information


    Ready to speak to a Thermo Fisher representative?

    We will be happy to answer your questions and provide a demo of our NGS solutions.

    For Research Use Only. Not for use in diagnostic procedures.